Individualized Blood Pressure Treatment: a Multidisciplinary Approach to Uncontrolled Hypertension in Order to Reduce Morbidity and Mortality

Oslo University Hospital1 site in 1 country1,000 target enrollmentNovember 1, 2017

ConditionsUncontrolled Hypertension

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Uncontrolled Hypertension
Sponsor: Oslo University Hospital
Enrollment: 1000
Locations: 1
Primary Endpoint: Blood pressure control
Status: Active, not recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of the study is to investigate and explore the most important aspects of drug-adherence in the treatment of hypertension in order to improve treatment and blood pressure control, implying that new knowledge will reduce morbidity and mortality.

Registry

clinicaltrials.gov

Start Date

November 1, 2017

End Date

December 31, 2025

Last Updated

last year

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Oslo University Hospital

Responsible Party

Principal Investigator

Sverre Erik Kjeldsen

Professor

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

•Signed informed consent
•Uncontrolled hypertension
•A stable medication regimen for at least 4 weeks of ≥ 2 antihypertensive agents
•No planned changes in antihypertensive drugs

Exclusion Criteria

•Withdrawal of consent
•24-h systolic ambulatory blood pressure \>/= 170 mmHg
•Patients with inadequate Norwegian language skills
•Positive pregnancy test
•Known alcohol or drug abuse
•estimated glomerular filtration rate \<30 mL/min/1.73m2
•Albumin/creatinin ratio \>300 mg/mmol
•Any reason why, in the opinion of the investigator, the patient should not participate